Skip to content

Clinical study on the treatment of premature ovarian insufficiency with Yishen Tiaojing Pill

Clinical study on the treatment of premature ovarian insufficiency with Yishen Tiaojing Pill

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300070821
Enrollment
Unknown
Registered
2023-04-24
Start date
2023-05-01
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

premature ovarian insufficiency

Interventions

Yishen Tiaojing Pill Group:Yishen Tiaojing Pill, 10g each time, twice a day, taken orally. Three menstrual cycles are treated as one course of treatment.

Sponsors

Jingzhou Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Patients who meet the diagnostic criteria of POI Western medicine. 2. Patients who meet the diagnostic criteria of POI in traditional Chinese medicine. 3. Patients have informed consent and voluntarily participate in the study.

Exclusion criteria

Exclusion criteria: 1. There are congenital physiological defects or deformities, organic lesions of the reproductive organs, and chromosomal abnormalities. 2. Abnormal thyroid function, hyperprolactinemia, endometriosis, congenital adrenal cortical hyperplasia. 3. Patients with severe primary diseases such as heart, liver, kidney, brain, and blood system, as well as mental illness, are combined. 4. Patients who are allergic to the medication used. 5. Patients who are taking hormone medications such as glucocorticoids and oral contraceptives. 6. Patients participating in clinical trials of other drugs.

Design outcomes

Primary

MeasureTime frame
AMH;FSH;AFC;

Secondary

MeasureTime frame
LH;E2;Ovarian volume;

Countries

China

Contacts

Public ContactSunTing

Jingzhou Traditional Chinese Medicine Hospital

136807166@qq.com+86 15927865234

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026